Official websites use .gov
Secure .gov websites use HTTPS
Titles
- Medicare Part D: a first look at plan offerings in 20161
- Medicare Part D: a first look at prescription drug plans in 20181
- Medicare Part D: a first look at prescription drug plans in 20191
- Medicare's income-related premiums under current law and changes for 20191
- No limit: Medicare Part D enrollees exposed to high out-of-pocket drug costs without a hard cap on spending1
- Part D plans generally include drugs commonly used by dual eligibles: 20191
- Prescription drugs: Department of Veterans Affairs paid about half as much as Medicare Part D for selected drugs in 2017 : report to the Ranking Member, Committee on the Budget, U.S. Senate1
- Prescription drugs: U.S. prices for selected brand drugs were higher on average than prices in Australia, Canada, and France : report to the Chairman, Committee on the Budget, U.S. Senate1
- Prescription drugs: spending, use, and prices1
- Prices for and spending on specialty drugs in Medicare Part D and Medicaid1
- Prices for and spending on specialty drugs in Medicare Part D and Medicaid: an in-depth analysis1
- Prices for top Medicare Part D drugs have more than tripled since entering the market1
- Projected impacts for Asian Medicare enrollees1
- Projected impacts for Black Medicare enrollees1
- Projected impacts for Latino Medicare enrollees1
- Questionable billing for compounded topical drugs in Medicare Part D1
- Rebates for brand-name drugs in Part D substantially reduced the growth in spending from 2011 to 20151
- Rx Watchdog report: comparative measures of price change for prescription drugs and other goods1
- Rx price watch report: trends in retail prices of brand name prescription drug widely used by Medicare beneficiaries : 2005 to 20091
- Rx price watch report: trends in retail prices of generic prescription drugs widely used by Medicare beneficiaries : 2005 to 20091